Cargando…

Adiponectin as a Biomarker of Osteoporosis in Postmenopausal Women: Controversies

The literature reports indicating a link between plasma levels of adiponectin and body fat, bone mineral density, sex hormones, and peri- and postmenopausal changes, draw attention to the possible use of adiponectin as an indicator of osteoporotic changes, suggesting that adiponectin may also modula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lubkowska, Anna, Dobek, Aleksandra, Mieszkowski, Jan, Garczynski, Wojciech, Chlubek, Dariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925580/ https://www.ncbi.nlm.nih.gov/pubmed/24591772 http://dx.doi.org/10.1155/2014/975178

Ejemplares similares

Whole-body vibration exercise in postmenopausal osteoporosis
por: Weber-Rajek, Magdalena, et al.
Publicado: (2015)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Adiponectin and Asthma: Knowns, Unknowns and Controversies
por: Otelea, Marina Ruxandra, et al.
Publicado: (2021)

Anabolic treatments for osteoporosis in postmenopausal women
por: Hassan, Neelam, et al.
Publicado: (2021)

The Levels of Bioelements in Postmenopausal Women with Metabolic Syndrome
por: Cybulska, Anna Maria, et al.
Publicado: (2022)

Evolving role of adiponectin in cancer-controversies and update
por: Katira, Arnav, et al.
Publicado: (2016)

The Controversial Role of Adiponectin in Appetite Regulation of Animals
por: Tang, Ni, et al.
Publicado: (2021)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
por: Min, Yong-Ki
Publicado: (2015)

Progress in osteoporosis and fracture prevention: focus on postmenopausal women
por: Saag, Kenneth G, et al.
Publicado: (2009)

Analysis of Relations Between the Level of Mg, Zn, Ca, Cu, and Fe and Depressiveness in Postmenopausal Women
por: Szkup, Małgorzata, et al.
Publicado: (2016)

Osteoporosis and Periodontitis in Postmenopausal Women: A Systematic Review
por: Goyal, Lata, et al.
Publicado: (2017)

Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review
por: Migliorini, Filippo, et al.
Publicado: (2021)

Effects of Yogasanas on osteoporosis in postmenopausal women
por: Motorwala, Zainab S, et al.
Publicado: (2016)

Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Sambrook, Philip
Publicado: (2007)

Identification of gene biomarkers in patients with postmenopausal osteoporosis
por: Yang, Chenggang, et al.
Publicado: (2019)

New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection
por: Korbecki, Jan, et al.
Publicado: (2018)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012)

Serum adiponectin levels are associated with worse cognitive function in postmenopausal women
por: De Franciscis, Pasquale, et al.
Publicado: (2017)

Relationships between Follicle-Stimulating Hormone and Adiponectin in Postmenopausal Women
por: Huang, Wan-Yu, et al.
Publicado: (2020)

Nutritional education in the primary prevention of osteoporosis in perimenopausal and postmenopausal women
por: Woźniak-Holecka, Joanna, et al.
Publicado: (2014)

Up-to-Date Knowledge on Osteoporosis Treatment Selection in Postmenopausal Women
por: Jeong, Hye Gyeong, et al.
Publicado: (2022)

Ddx4(+) Oogonial Stem Cells in Postmenopausal Women’s Ovaries: A Controversial, Undefined Role
por: Silvestris, Erica, et al.
Publicado: (2019)

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
por: Rizzoli, René, et al.
Publicado: (2011)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

New insights into treatment of osteoporosis in postmenopausal women
por: Geusens, Piet
Publicado: (2015)

Gingival recession in postmenopausal women with and without osteoporosis
por: DUNCEA, IOANA, et al.
Publicado: (2013)

The Interface between Osteoporosis and Atherosclerosis in Postmenopausal Women
por: Lopes, Neuza H. M.
Publicado: (2018)

Factors related with osteoporosis treatment in postmenopausal women
por: Rossi, Lia Mara Montagner, et al.
Publicado: (2018)

Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis
por: Yang, Weiwei, et al.
Publicado: (2022)

Height Loss Is an Independent Predictor of Fracture Incidence in Postmenopausal Women: The Results from the Gliwice Osteoporosis Study (GO Study)
por: Pluskiewicz, Wojciech, et al.
Publicado: (2023)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ctpirhula817kf0jgdrts2qq1u